THU (Temple University Hospital) and the Shock Trauma Center at the University of Maryland Medical Center are planning a clinical trial to explore use of HBOT emergency care for Traumatic Brain Injury. HBOT (Hyperbaric Oxygen Therapy) has long been regarded as the standard of care in many areas of emergency medicine such as diving accidents and carbon monoxide poisoning. Recent research in the U.S., extensive clinical experience and worldwide studies have shown the HBOT is effective in treating TBI and concussion. The Israeli Defense Forces use HBOT at a first line treatment for any head injury. Trials such as this are critical to establishing the value of HBOT in emergency medicine in the U.S.
This trial will be part of the National Institutes of Health Strategies to Innovate Emergency Care Clinical Trials Network (SIREN). The focus of SIREN is finding and implementing early treatment for trauma and neurological, heart, lung, and blood disorders. According to Dr. Nina Gentile, Professor of Emergency Medicine at Temple, “Without this type of network in place, it’s tough to piece together the best way to treat people.” For patients in trials such as this, treatment will include a multi-disciplinary team from the ambulance and the ER to neurosurgeons. The SIREN trials are funded by the NIH’s National Heart, Lung and Blood Institute and the National Institute of Neurological Disorders and Stroke.
Learn more about Hyberbaric Oxygen therapy